Precigen Inc (PGEN)
1.28
-0.01
(-0.78%)
USD |
NASDAQ |
May 10, 16:00
1.28
0.00 (0.00%)
After-Hours: 20:00
Precigen Enterprise Value: 258.25M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 258.25M |
| May 08, 2024 | 268.21M |
| May 07, 2024 | 280.65M |
| May 06, 2024 | 295.59M |
| May 03, 2024 | 290.61M |
| May 02, 2024 | 285.63M |
| May 01, 2024 | 285.63M |
| April 30, 2024 | 265.72M |
| April 29, 2024 | 285.63M |
| April 26, 2024 | 288.12M |
| April 25, 2024 | 285.63M |
| April 24, 2024 | 290.61M |
| April 23, 2024 | 285.63M |
| April 22, 2024 | 280.65M |
| April 19, 2024 | 268.21M |
| April 18, 2024 | 265.72M |
| April 17, 2024 | 263.23M |
| April 16, 2024 | 275.68M |
| April 15, 2024 | 285.63M |
| April 12, 2024 | 290.61M |
| April 11, 2024 | 298.08M |
| April 10, 2024 | 288.12M |
| April 09, 2024 | 288.12M |
| April 08, 2024 | 288.12M |
| April 05, 2024 | 285.63M |
| Date | Value |
|---|---|
| April 04, 2024 | 275.68M |
| April 03, 2024 | 285.63M |
| April 02, 2024 | 283.14M |
| April 01, 2024 | 293.10M |
| March 28, 2024 | 298.08M |
| March 27, 2024 | 298.08M |
| March 26, 2024 | 285.63M |
| March 25, 2024 | 286.88M |
| March 22, 2024 | 284.39M |
| March 21, 2024 | 317.99M |
| March 20, 2024 | 295.59M |
| March 19, 2024 | 295.59M |
| March 18, 2024 | 283.14M |
| March 15, 2024 | 293.10M |
| March 14, 2024 | 293.10M |
| March 13, 2024 | 315.50M |
| March 12, 2024 | 311.77M |
| March 11, 2024 | 324.21M |
| March 08, 2024 | 372.75M |
| March 07, 2024 | 352.84M |
| March 06, 2024 | 355.33M |
| March 05, 2024 | 337.90M |
| March 04, 2024 | 342.88M |
| March 01, 2024 | 357.82M |
| February 29, 2024 | 320.48M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
147.81M
Minimum
Nov 13 2023
2.127B
Maximum
Jan 04 2021
765.01M
Average
664.93M
Median
Enterprise Value Benchmarks
| Cyclacel Pharmaceuticals Inc | -0.3327M |
| HealthEquity Inc | 7.153B |
| Corvus Pharmaceuticals Inc | 72.40M |
| Oragenics Inc | 4.605M |
| MAIA Biotechnology Inc | 52.33M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -33.06M |
| Revenue (Quarterly) | 1.228M |
| Total Expenses (Quarterly) | 24.62M |
| EPS Diluted (Quarterly) | -0.13 |
| Gross Profit Margin (Quarterly) | -10.59% |
| Profit Margin (Quarterly) | -2.69K% |
| Earnings Yield | -30.47% |
| Normalized Earnings Yield | -27.10 |